Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms

To the editor: Recently, inhibition of lysine-specific demethylase 1 (LSD1) has gained attention as a potential novel treatment in acute myeloid leukemia (AML).[1][1][⇓][2]-[3][3] However, expression in other hematologic neoplasms has not been examined. LSD1 is a central epigenetic regulator of